SCHEMBL9101981

SCHEMBL9101981

COc1ccc2c(c1)CC(=O)N2C(CC(C)C)C(=O)Nc1cnccn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
POLB P06746 2/20 0.43
GCK P35557 2/20 0.38
RIOK2 Q9BVS4 4/20 0.38
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GAA P10253 1/20 0.37
THRB P10828 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
CYP2D6 P10635 1/20 0.37
HRH1 P35367 1/20 0.37
KCNH2 Q12809 1/20 0.37
FFAR2 O15552 1/20 0.37
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9908093 1.00 KDM4E (0.43) KDM4EPOLBGCKRIOK2RAB9A
SCHEMBL9908089 0.91 RAB9A (0.37) KDM4EPOLBGCKRAB9ASMN1; SMN2
SCHEMBL9108208 0.91 RAB9A (0.37) KDM4EPOLBGCKRAB9ASMN1; SMN2
SCHEMBL9103283 0.89 F2 (0.42) KDM4EPOLBGCKRIOK2RAB9A
SCHEMBL9908105 0.89 RAB9A (0.43) KDM4EPOLBGCKRAB9ASMN1; SMN2
SCHEMBL9108970 0.89 RAB9A (0.43) KDM4EPOLBGCKRAB9ASMN1; SMN2
SCHEMBL9103176 0.88 GAA (0.38) KDM4EPOLBGCKRAB9AGAA
SCHEMBL9908112 0.88 FFAR2 (0.46) KDM4EPOLBGCKRAB9ASMN1; SMN2
SCHEMBL9106629 0.88 FFAR2 (0.46) KDM4EPOLBGCKRAB9ASMN1; SMN2
SCHEMBL9908099 0.88 GAA (0.38) KDM4EPOLBGCKRAB9AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US claimed
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS KESTER ROBERT FRANCIS (US) 2012-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142705-A1 ISATIN AND OXINDOLE COMPOUNDS GPR119, INSR, OAT KDM4E 4421/4885POLB 3911/4885GCK 488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.